Torrent Pharmaceuticals Limited has informed the Exchange about issue of Securities
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty 100 and 0.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Torrent Pharmaceuticals has issued Commercial Papers (CPs) amounting to ₹200 Crores on 20th June 2025. The CPs carry a coupon rate of 5.95% per annum, with interest paid upfront at the time of issue. The tenure is 90 days, with maturity scheduled for 18th September 2025. The instrument is unsecured and is proposed to be listed on the National Stock Exchange (NSE). This is a short-term money market borrowing to meet routine working capital or short-term funding needs.
This is a routine short-term treasury operation and not a material capital-raising event. The ₹200 Crore size is small relative to the company's scale, and the 5.95% rate suggests healthy access to funds at reasonable cost. No meaningful impact expected on the stock price or shareholders.